Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03867461 · ClinicalTrials.gov registry record · NA
The Effects of MAP and EtCO2 on Venous Sinus Pressures
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT03867461: Completed NA study, sponsored by Wake Forest University Health Sciences.
NCT03867461 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03867461, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to further elaborate the role of both arterial blood pressure and end-tidal carbon dioxide concentration on measured venous pressures.
Interventions
- PROCEDURE Venous Sinus Stenting
- OTHER Adjustment to end-tidal carbon dioxide concentrations ( 38-40 mmHg range)
- OTHER Adjustment to Mean Arterial Pressure (100-110 mmHg range)
- OTHER Adjustment to Mean Arterial Pressure (60-80 mmHg range)
- OTHER Adjustment to end-tidal carbon dioxide concentrations (24-26 mmHg range)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2019-06-20 |
| Est. Completion | 2019-09-25 |
| Phase | NA |
What the finished NCT03867461 record still lists
NCT03867461 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 5 interventions - of which Venous Sinus Stenting is the first listed.
NCT03867461 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03867461 about?
NCT03867461 is a clinical study titled "The Effects of MAP and EtCO2 on Venous Sinus Pressures". The purpose of this study is to further elaborate the role of both arterial blood pressure and end-tidal carbon dioxide concentration on measured venous pressures.
What is the current status of trial NCT03867461?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2019-06-20. Estimated completion is 2019-09-25.
What interventions are being tested in trial NCT03867461?
The interventions under investigation include: Venous Sinus Stenting (PROCEDURE), Adjustment to end-tidal carbon dioxide concentrations ( 38-40 mmHg range) (OTHER), Adjustment to Mean Arterial Pressure (100-110 mmHg range) (OTHER), Adjustment to Mean Arterial Pressure (60-80 mmHg range) (OTHER), Adjustment to end-tidal carbon dioxide concentrations (24-26 mmHg range) (OTHER).
Who is sponsoring clinical trial NCT03867461?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03867461's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI